Comparative effect of antihypertensive therapy on blood glucose level in hypertensive patients in an Indian population
© Georg Thieme Verlag KG Stuttgart · New York..
Hypertensive patients have higher prevalence of insulin resistance and are at increased risk of developing type 2 diabetes mellitus (DM). There is scarcity of data on the relationship between antihypertensive therapies and glycaemic control in Indian population. Thus, the present study was designed to investigate such association among Indian population in a University teaching hospital.The study was carried out on 177 hypertensive patients (with new onset of diabetes or without diabetes) visiting the OPD of medicine department at Majeedia hospital, New Delhi. The drug history of hypertensive patients and blood glucose levels following 1-5 yrs of antihypertensive therapy were recorded.The gender distribution of hypertensive patients reveals a higher percentage of incidences in males (53.7%) as compared to females (46.3%). Hypertensive patient without DM on beta blockers and on thiazide shows higher incidence of impaired glucose tolerance (IGT) (17.5%, 18.5%) and DM (10%, 11%) as compared to patient receiving other antihypertensive therapy. While in patients of new onset diabetes the incidence was higher with β-blockers (56.2%) than with thiazides (31.3%) followed by calcium channel blockers (CCBs) (12.5%). There was proportionate increase in incidence with the duration of therapy (3-5 years). None of the patients who were on ACE inhibitors or on angiotensin receptor blockers (ARBs) reported any incidence of IGT or DM.To conclude, β-blockers and thiazides increases the risk of type 2 diabetes mellitus with long term antihypertensive therapy requiring regular monitoring. CCBs have lowered risks while ACE inhibitors and ARBs are relatively free of such metabolic adverse effects.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:64 |
---|---|
Enthalten in: |
Drug research - 64(2014), 5 vom: 07. Mai, Seite 276-80 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ahmad, M A [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adrenergic beta-Antagonists |
---|
Anmerkungen: |
Date Completed 29.12.2014 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1055/s-0033-1357202 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM231765541 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM231765541 | ||
003 | DE-627 | ||
005 | 20231224091512.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1055/s-0033-1357202 |2 doi | |
028 | 5 | 2 | |a pubmed24n0772.xml |
035 | |a (DE-627)NLM231765541 | ||
035 | |a (NLM)24132701 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ahmad, M A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Comparative effect of antihypertensive therapy on blood glucose level in hypertensive patients in an Indian population |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.12.2014 | ||
500 | |a Date Revised 07.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © Georg Thieme Verlag KG Stuttgart · New York. | ||
520 | |a Hypertensive patients have higher prevalence of insulin resistance and are at increased risk of developing type 2 diabetes mellitus (DM). There is scarcity of data on the relationship between antihypertensive therapies and glycaemic control in Indian population. Thus, the present study was designed to investigate such association among Indian population in a University teaching hospital.The study was carried out on 177 hypertensive patients (with new onset of diabetes or without diabetes) visiting the OPD of medicine department at Majeedia hospital, New Delhi. The drug history of hypertensive patients and blood glucose levels following 1-5 yrs of antihypertensive therapy were recorded.The gender distribution of hypertensive patients reveals a higher percentage of incidences in males (53.7%) as compared to females (46.3%). Hypertensive patient without DM on beta blockers and on thiazide shows higher incidence of impaired glucose tolerance (IGT) (17.5%, 18.5%) and DM (10%, 11%) as compared to patient receiving other antihypertensive therapy. While in patients of new onset diabetes the incidence was higher with β-blockers (56.2%) than with thiazides (31.3%) followed by calcium channel blockers (CCBs) (12.5%). There was proportionate increase in incidence with the duration of therapy (3-5 years). None of the patients who were on ACE inhibitors or on angiotensin receptor blockers (ARBs) reported any incidence of IGT or DM.To conclude, β-blockers and thiazides increases the risk of type 2 diabetes mellitus with long term antihypertensive therapy requiring regular monitoring. CCBs have lowered risks while ACE inhibitors and ARBs are relatively free of such metabolic adverse effects | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Adrenergic beta-Antagonists |2 NLM | |
650 | 7 | |a Angiotensin Receptor Antagonists |2 NLM | |
650 | 7 | |a Angiotensin-Converting Enzyme Inhibitors |2 NLM | |
650 | 7 | |a Antihypertensive Agents |2 NLM | |
650 | 7 | |a Blood Glucose |2 NLM | |
650 | 7 | |a Calcium Channel Blockers |2 NLM | |
700 | 1 | |a Kapur, P |e verfasserin |4 aut | |
700 | 1 | |a Khanam, R |e verfasserin |4 aut | |
700 | 1 | |a Akhtar, M |e verfasserin |4 aut | |
700 | 1 | |a Khan, G H |e verfasserin |4 aut | |
700 | 1 | |a Anwar, M J |e verfasserin |4 aut | |
700 | 1 | |a Vohora, D |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Drug research |d 2013 |g 64(2014), 5 vom: 07. Mai, Seite 276-80 |w (DE-627)NLM225192764 |x 2194-9387 |7 nnns |
773 | 1 | 8 | |g volume:64 |g year:2014 |g number:5 |g day:07 |g month:05 |g pages:276-80 |
856 | 4 | 0 | |u http://dx.doi.org/10.1055/s-0033-1357202 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 64 |j 2014 |e 5 |b 07 |c 05 |h 276-80 |